Week 7 Assignment: Study Guide for Medication for Treatment of Schizophrenia Spectrum & Other Psychosis Disorders: Olanzapine (Zyprexa) Master of Science in Nursing, Walden University NURS 6630: Psychopharmacological Approaches to Treat Psychopathology July 15, 2022

Study Guide for Olanzapine (Zyprexa)2 The guidelines for managing schizophrenic patients focus on reducing positive symptoms in the patient, directly linked to the psychotic status (American Psychiatric Association, 2020). Antipsychotic drugs such as clozapine and olanzapine act on the dopamine receptors (D1, D2). The relative potency, range of side effects, and history of medication response in the patient and his or her family should all be taken into consideration when selecting an antipsychotic medicine (McClellan & Werry, 1997). All antipsychotics, with the exception of clozapine, have been associated with extrapyramidal symptoms, anticholinergic symptoms, withdrawal dyskinesia, and tardive dyskinesia. as well as the neuroleptic malignant syndrome (McClellan & Werry, 1997). Stern et al. (2016) explain that treatment of schizophrenia explores the use of first and second-generation antipsychotics. In order to safely prescribe antipsychotic medications, it is crucial for the Psychiatric Mental Health Nurse Practitioner (PMHNP) to have a knowledge of the pharmacokinetic, pharmacodynamic effects of the drug. The purpose of this paper is to present a study guide for the assigned psychotropic medication agent, Olanzapine. Olanzapine belongs to the class of second-generation (atypical) antipsychotic medications used in the treatment of Schizophrenia spectrum and other psychosis disorders. This study guide is in the form of an outline with references, which incorporates visual elements such as concept maps, charts, diagrams, images, color coding, and mnemonics. The study guide is informed by the FDA-approved

Study Guide for Olanzapine (Zyprexa)3 and Evidenced-Based, Clinical Practice Guidelines Research and supported by other scholarly resources